A woman comes in with a PCOS diagnosis she received years ago. She was told her ovaries had cysts, offered birth control to regulate her cycles, and advised to lose weight. Nobody explained why the weight would not come off, why the fatigue after meals was so pronounced, or why the condition seemed to affect so much more than her periods. She left with a label and a prescription, but not an explanation.
Why the name changed, and why it matters
That gap has now been formally acknowledged at the highest levels of endocrinology. In May 2026, after fourteen years of global collaboration, the condition long known as polycystic ovary syndrome was officially renamed. And the reason for the change tells you almost everything you need to know about what has been missing from the conversation.
The condition is now called polyendocrine metabolic ovarian syndrome, or PMOS. The change was published in The Lancet and endorsed by more than fifty patient and professional organizations, including the Endocrine Society.
The rationale is worth reading carefully. According to the Endocrine Society, the old name reduced a complex, long-term hormonal and endocrine disorder to a misunderstanding about cysts and a focus on the ovaries, and that misunderstanding contributed to missed diagnoses and inadequate treatment. The new name leads with the hormonal and metabolic dimensions of the condition, because that is where its true weight lies.
In other words, the global consensus is that this was never primarily an ovarian problem. It is a metabolic and endocrine one. The name is catching up to the biology. Practically speaking, patients should not expect anything about their diagnosis or care to change overnight; the transition is planned over roughly three years. But the reframing has immediate implications for how the condition ought to be understood and evaluated.
The metabolic engine underneath
For a great many women with PCOS, insulin resistance sits close to the center of the picture, and it is the piece most often left unexplained.
Insulin is the hormone that moves glucose out of the bloodstream and into cells. When cells respond poorly to it, the body compensates by producing more. Those elevated insulin levels do not stay in their lane. They stimulate the ovaries to produce additional androgens, the hormones responsible for many of the symptoms women find most distressing, including irregular or absent ovulation, acne, and unwanted hair growth. Higher insulin also promotes fat storage and makes fat loss substantially harder, which is precisely why “just lose weight” is such unsatisfying advice when the metabolic machinery is working against you.
It is a self-reinforcing loop. Insulin resistance drives androgen excess, androgen excess and weight gain worsen insulin resistance, and the cycle tightens. Understanding that loop is what makes the condition tractable rather than mystifying.
You do not have to be overweight to have it
This deserves its own heading, because it is where a great many women fall through the cracks.
Insulin resistance in this condition is not confined to women who carry excess weight. It occurs in lean women as well, and when it does, it is frequently missed entirely, because the clinical picture does not match the assumption. A woman at a normal weight with irregular cycles and acne may never have her metabolic health evaluated at all, on the reasoning that she does not look like someone with a metabolic problem.
If you have been told your weight is normal and therefore this is not a metabolic issue, that reasoning does not hold. It is worth asking for the testing regardless.
Why this is about more than fertility
Because the old framing centered on the ovaries, the long-term stakes were often underplayed. They should not be. The metabolic dimension of this condition carries real downstream consequences: elevated risk of impaired glucose tolerance and type 2 diabetes, gestational diabetes, unfavorable cholesterol patterns, high blood pressure, and cardiovascular disease.
That is not offered to alarm anyone. It is offered because those risks are modifiable, and because they are the strongest argument for treating this as a whole-body condition managed over decades rather than a menstrual problem managed with a pill. Cycle regularity matters. So does the metabolic trajectory underneath it.
What a fuller evaluation looks like
If insulin resistance is a central driver, it follows that it should be measured rather than assumed. A more complete workup generally looks at fasting glucose and fasting insulin, hemoglobin A1c, a lipid panel, and androgen levels, alongside a careful history of your cycles, your symptoms, and your family history. Related conditions worth ruling out include thyroid dysfunction, which can produce overlapping symptoms.
Cycle-related symptoms such as those seen in PMS can also complicate the picture, which is another reason the evaluation should consider your hormonal patterns as a whole rather than any single marker in isolation. The point of the broader panel is not to order tests for their own sake. It is to find out what is actually driving your symptoms, so that the plan addresses the cause rather than just the most visible effect.
How it is managed
Management works best when it addresses both the symptoms and the metabolic engine driving them.
On the metabolic side, the interventions are meaningful and well-supported. Nutrition that stabilizes blood sugar, regular physical activity including resistance training, adequate sleep, and stress management all improve insulin sensitivity, and improving insulin sensitivity often improves androgen levels and cycle regularity as a downstream effect. Correcting relevant nutrient deficiencies can help as well. For some women, medications that improve insulin sensitivity, such as metformin, are appropriate, and that is a conversation to have with your physician.
Conventional treatments retain their place. Hormonal contraceptives can effectively manage cycle irregularity, acne, and unwanted hair growth for women who want that, and they should not be dismissed. The distinction worth drawing is that they manage symptoms rather than address the metabolic driver, so for many women the most complete approach uses both: symptom management where it is wanted, and metabolic work underneath it. Where broader hormonal evaluation is warranted, that fits into the same fuller picture.
There is no cure for this condition, and I would be skeptical of anyone who claims otherwise. What there is, reliably, is meaningful improvement in symptoms and a materially better long-term health trajectory when the metabolic side is taken seriously.
When to seek care
If you have a PCOS diagnosis and were never evaluated for insulin resistance, that is a reasonable gap to close. If you have been told to lose weight without being told why it is so difficult, you deserve a better explanation. And if you have irregular cycles, acne, unwanted hair growth, or difficulty conceiving without a diagnosis at all, a thorough hormonal and metabolic workup is a sensible starting point.
If any of that describes you, I would be glad to help you get a clearer picture. Schedule a complimentary consultation to review your history and labs and discuss a sensible next step, or call us at (480) 442-8999. We see patients at both our Arizona and Oregon clinics.
This article is provided for educational purposes only and is not a substitute for professional medical diagnosis or treatment. Do not start, stop, or change any prescribed medication without consulting your physician. Individual results vary.
Frequently asked questions
Does everyone with PCOS have insulin resistance?
Not everyone, but it is common, and it is a central feature for a large share of women with the condition. It also occurs in women who are not overweight, where it is frequently overlooked. Because it is both common and consequential, and because it is straightforward to test for, it is worth evaluating rather than assuming either way.
Is PCOS now called PMOS?
Yes. In May 2026, a global consensus published in The Lancet renamed the condition polyendocrine metabolic ovarian syndrome (PMOS), reflecting that it is a hormonal and metabolic condition rather than a primarily ovarian one. The transition is expected to take about three years, and both terms will be in use during that period. Your diagnosis and treatment do not change because of the name.
Can you have PCOS without ovarian cysts?
Yes, and this was a central reason for the name change. Research accompanying the renaming found no increase in abnormal ovarian cysts in the condition, and cysts have never been required for diagnosis. Many women are told their ultrasound is normal and conclude they cannot have the condition, when the ovaries are only one component of the diagnostic picture and not the most important one.
Can improving insulin resistance help my symptoms?
For many women, yes. Because elevated insulin stimulates androgen production, improving insulin sensitivity through nutrition, physical activity, sleep, and where appropriate medication can lead to improvements in cycle regularity, acne, and unwanted hair growth over time. It is not an overnight fix, and results vary, but it addresses the driver rather than only the symptoms.